BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21051688)

  • 21. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxcarbazepine-induced syndrome of inappropriate secretion of antidiuretic hormone.
    Cilli AS; Algun E
    J Clin Psychiatry; 2002 Aug; 63(8):742. PubMed ID: 12197457
    [No Abstract]   [Full Text] [Related]  

  • 26. Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
    Leinonen E; Lepola U; Koponen H
    Pharmacopsychiatry; 1996 Jul; 29(4):156-8. PubMed ID: 8858715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priapism associated with oxcarbazepine, aripiprazole, and lithium.
    Negin B; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223-4. PubMed ID: 16292111
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse effects of established and new antiepileptic drugs: an attempted comparison.
    Rogvi-Hansen B; Gram L
    Pharmacol Ther; 1995; 68(3):425-34. PubMed ID: 8788565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants].
    Bayer A; Thiel HJ; Zrenner E; Paulus W; Ried S; Schmidt D
    Nervenarzt; 1995 Feb; 66(2):89-96. PubMed ID: 7715759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin-diazepam interaction.
    Murphy A; Wilbur K
    Ann Pharmacother; 2003 May; 37(5):659-63. PubMed ID: 12708941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-onset hypersensitivity reaction with leukopenia and thrombocytopenia induced by oxcarbazepine treatment in a patient with schizoaffective disorder.
    Yeh YW; Wang TY; Huang CC; Chen YC
    J Clin Psychiatry; 2008 Apr; 69(4):676-8. PubMed ID: 18507488
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
    Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
    J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine for the treatment of trichotillomania.
    Leombruni P; Gastaldi F
    Clin Neuropharmacol; 2010; 33(2):107-8. PubMed ID: 20375658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of old and new anticonvulsants in treatment of psychiatric diseases].
    Walden J; Hesslinger B
    Fortschr Neurol Psychiatr; 1995 Aug; 63(8):320-35. PubMed ID: 7557815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
    Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
    Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.